Current status of recurrent glioblastoma therapies

Research output: Chapter in Book/Report/Conference proceedingChapter


Almost 100% glioblastoma (GBM) recurs following extensive therapies. Current strategies of treatment of recurrent GBM varies from center to center and it depends on the site, size, and vascularity of the recurrent tumors. In this chapter, current views of managing recurrent GBM is discussed and also possible alternative intervention is pointed out.

Original languageEnglish (US)
Title of host publicationNew Targeting in the Reversal of Resistant Glioblastomas
Number of pages7
ISBN (Electronic)9780128225271
ISBN (Print)9780128232767
StatePublished - Jan 1 2021


  • Avastin
  • Current therapies
  • Glioblastoma (GBM)
  • Immunotherapies
  • Radiation
  • Temozolomide

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Current status of recurrent glioblastoma therapies'. Together they form a unique fingerprint.

Cite this